Page last updated: 2024-10-27

fenoldopam and Brain Neoplasms

fenoldopam has been researched along with Brain Neoplasms in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
"Fenoldopam is a direct-acting vasodilator that acts at the postsynaptic dopamine 1 receptors in renal, coronary, cerebral, and splanchnic vasculature resulting in arterial dilation and a lowering of the mean arterial pressure (MAP)."2.40Initial experience with fenoldopam in children. ( Pruitt, RD; Strauser, LM; Tobias, JD, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strauser, LM1
Pruitt, RD1
Tobias, JD1

Reviews

1 review available for fenoldopam and Brain Neoplasms

ArticleYear
Initial experience with fenoldopam in children.
    American journal of therapeutics, 1999, Volume: 6, Issue:5

    Topics: Age Factors; Antihypertensive Agents; Body Weight; Brain Neoplasms; Child; Dopamine Agonists; Emerge

1999